Correlation Between Chengdu Kanghua and China Reform

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chengdu Kanghua and China Reform at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chengdu Kanghua and China Reform into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chengdu Kanghua Biological and China Reform Health, you can compare the effects of market volatilities on Chengdu Kanghua and China Reform and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chengdu Kanghua with a short position of China Reform. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chengdu Kanghua and China Reform.

Diversification Opportunities for Chengdu Kanghua and China Reform

0.79
  Correlation Coefficient

Poor diversification

The 3 months correlation between Chengdu and China is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Chengdu Kanghua Biological and China Reform Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on China Reform Health and Chengdu Kanghua is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chengdu Kanghua Biological are associated (or correlated) with China Reform. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of China Reform Health has no effect on the direction of Chengdu Kanghua i.e., Chengdu Kanghua and China Reform go up and down completely randomly.

Pair Corralation between Chengdu Kanghua and China Reform

Assuming the 90 days trading horizon Chengdu Kanghua Biological is expected to generate 0.93 times more return on investment than China Reform. However, Chengdu Kanghua Biological is 1.07 times less risky than China Reform. It trades about -0.22 of its potential returns per unit of risk. China Reform Health is currently generating about -0.37 per unit of risk. If you would invest  5,671  in Chengdu Kanghua Biological on October 24, 2024 and sell it today you would lose (513.00) from holding Chengdu Kanghua Biological or give up 9.05% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Chengdu Kanghua Biological  vs.  China Reform Health

 Performance 
       Timeline  
Chengdu Kanghua Biol 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Chengdu Kanghua Biological has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
China Reform Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days China Reform Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Chengdu Kanghua and China Reform Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chengdu Kanghua and China Reform

The main advantage of trading using opposite Chengdu Kanghua and China Reform positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chengdu Kanghua position performs unexpectedly, China Reform can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Reform will offset losses from the drop in China Reform's long position.
The idea behind Chengdu Kanghua Biological and China Reform Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance